Table 1 Questions for assessing the reporting of ITCWM-specific items

Q1

Whether the feature of ITCWM was presented in Title?

Q2

Whether the eligibility criteria of participants included both Chinese and western medical diagnosis in Methods of Abstract?

Q3

Whether the study objectives or hypotheses were focused on the ITCWM interventions in Abstract?

Q4

Whether the outcome measures included both TCM and WM related endpoints in Abstract?

Q5

Whether the effect of studied ITCWM interventions was reported in Conclusion of Abstract?

Q6

Whether the feature or design of ITCWM study were reflected in Keywords?

Q7

Whether the reason/rationale about ITCWM intervention for the study design was reported in the Background?

Q8

Whether the objectives or hypotheses were focused on the ITCWM interventions in the Background?

Q9

Whether the eligibility criteria of participants included both Chinese and western medical diagnosis in Methods?

Q10

Whether the specific information of disease (e.g., classification of disease, treatment points, stages of diseases) of the ITCWM was reported in Methods?

Q11

Whether the specific type/way of integration of TCM and WM interventions (such as overlying, one-after-another, or add-on design) was reported in Methods?

Q12

In the ITCWM group, whether TCM intervention(s) was reported with sufficient details to allow replication, including how and when they were administered?

Q13

In the ITCWM group, whether WM intervention(s) was reported with sufficient details to allow replication, including how and when they were administered?

Q14

In the control group, whether sufficient details were reported to allow replication?

Q15

Whether the outcome measures included both TCM and WM related endpoints in Methods?

Q16

For the studies with open label, whether any reasons or explanations for such design was reported?

Q17

In the control group(s), did the placebo of WM invention(s) was included? If so, whether sufficient details were provided?

Q18

In the control group(s), did the placebo of TCM invention(s) was included? If so, whether sufficient details were provided?

Q19

In the section of Results, whether any information about the participants exposed to ITCWM treatment prior to recruitment was mentioned in the baseline data?

Q20

Whether interpretation and significance of studied ITCWM interventions for the disease was reported in Discussion?

Q21

Whether any potential conflicts of interests were clearly reported?